Home » Alnylam Gets Favorable Ruling in Patent Suit Against Tekmira
Alnylam Gets Favorable Ruling in Patent Suit Against Tekmira
Alnylam Pharmaceuticals said a U.S. federal court has ruled that it could sue Canada’s Tekmira Pharmaceuticals for infringing patents on lipid nanoparticle technology exclusively licensed to Alnylam.
Reuters
Reuters
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May